Status:
COMPLETED
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Venous Thromboembolism
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism is a common and fatal disease closely related to cancer. The therapeutic challenge is major due to the high risk of recurrent thromboembolism and bleeding in patients with cance...
Detailed Description
The aim of this study si to assess this proportion in a retrospective multicenter study, of patients admitted for acute Cancer-Associated venous Thromboembolism (CAT).
Eligibility Criteria
Inclusion
- Consecutive patients with a newly diagnosed, objectively confirmed:
- symptomatic or unsuspected Deep Vein Thrombosis (DVT) (any location)
- symptomatic or unsuspected Pulmonary Embolism (PE)
- Consecutive patients with any type of cancer whose primary brain tumor or known intracerebral metastases and acute leukemia that meets at least one of the following:
- Active cancer defined as diagnosis of cancer within six months or receiving treatment for cancer or any treatment for cancer or recurrent locally advanced or metastatic cancer.
- Cancer diagnosed within 2 years.
Exclusion
- pregnant women or breast feeding
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04846556
Start Date
April 1 2022
End Date
June 30 2022
Last Update
October 11 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens
Amiens, France, 80000
2
Hôpital Louis Mourier
Colombes, France, 92000
3
Chu Saint-Etienne
Saint-Etienne, France